News 2025

18.02.2025
Novel antibiotic BTZ-043 also reaches tuberculosis bacteria hiding in dead lung tissue
Every year, 10 million people contract tuberculosis (TB). Around 1.5 million patients succumb to the disease. The novel antibiotic BTZ-043 has shown good bactericidal activity in human clinical trials. DZIF scientists led by the University of Bayreuth and the FZB were able to show that BTZ-043 effectively penetrates TB lesions, accumulates there and can thus fight the Mtb bacteria even in hard-to-reach areas.

18.02.2025
Young scientist wins DZIF/DGI 2025 poster award
At this annual joint congress of the German Center for Infection Research (DZIF) and the German Society for Infectious Diseases (DGI) in Munich, Dariusz Wölk, medical student at the University of Hamburg and doctoral candidate in the Clinical Infectious Diseases group at the Research Center Borstel, Leibniz Lung Center, has been awarded 500 € for the best poster.

17.02.2025
EndTB trial: Shorter and highly effective treatments for drug-resistant tuberculosis
Treatment options for persons affected by drug-resistant tuberculosis are rapidly improving. While 2 years ago standard antibiotic therapy was still recommended for 18 months with then available medicines - leading to approximately 60% of individuals achieving treatment success - novel regimens for drug-resistant tuberculosis are shorter and more effective.

17.02.2025
PANGenS-Consortium Meeting in Windhoek, Namibia: Advancing TB and Malaria Sequencing Technology Across 12 African Countries
Scientists from the Noguchi Memorial Institute for Medical Research (NMIMR) in Ghana, the Research Center Borstel Leibniz Lung Center (RCB) in Germany, and partner institutions from across Africa and Europe gathered in Windhoek, Namibia, for the second annual meeting of the „Pan-African Network for Genomic Surveillance of Poverty Related Disease and Emerging Pathogens (PANGenS)“ consortium to discuss advancements in the capacity building strategy of this Global Health EDCTP3 funded initiative.

14.02.2025
Borsteler Biologielaborantinnen und Biologielaboranten verabschiedet
Am 31.01 wurden im Gartensaal des Borsteler Herrenhauses insgesamt 12 Biologielaborantinnen und Biologielaboranten in die Berufswelt entlassen und erhielten im Rahmen der offiziellen Entlassungsfeier ihre Zeugnisse und Gesellenbriefe. Gemeinsam mit ihren Familien, den Ausbildern und den Kolleginnen und Kollegen feierten Sie ihre großartigen Leistungen.